We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+8.01%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$20.1B
AUM Growth
+$3.5B
Cap. Flow
+$2.5B
Cap. Flow %
12.41%
Top 10 Hldgs %
33.13%
Holding
257
New
120
Increased
40
Reduced
39
Closed
20

Top Buys

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$546M
2
WTW icon
Willis Towers Watson
WTW
+$471M
3
MA icon
Mastercard
MA
+$344M
4
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$240M
5
BBL
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
+$238M

Top Sells

Rank Stock Value
1
TIF
Tiffany & Co.
TIF
+$301M
2
NYT icon
New York Times
NYT
+$209M
3
V icon
Visa
V
+$194M
4
ELV icon
Elevance Health
ELV
+$145M
5
ABBV icon
AbbVie
ABBV
+$123M

Sector Composition

Rank Sector Weight
1 Healthcare 35.71%
2 Technology 14.95%
3 Financials 13.65%
4 Communication Services 11.15%
5 Industrials 7.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PS
126
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
$10.1M 0.05%
+450,000
New +$9.65M
RKTA.U
127
DELISTED
Rocket Internet Growth Opportunities Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
RKTA.U
$10M 0.05%
+1,000,000
New +$10M
AAC.U
128
DELISTED
Ares Acquisition Corporation Units, each consisting of one Class A ordinary share, and one-fifth of one redeemable warrant
AAC.U
$10M 0.05%
+1,000,000
New +$10.2M
CVIIU
129
DELISTED
Churchill Capital Corp VII Units
CVIIU
$9.97M 0.05%
+1,000,000
New +$10.3M
PRDS
130
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$9.96M 0.05%
+1,000,000
New +$10.3M
CRZNU
131
DELISTED
Corazon Capital V838 Monoceros Corp Unit
CRZNU
$9.95M 0.05%
+1,000,000
New +$9.91M
VGII.U
132
DELISTED
Virgin Group Acquisition Corp. II Units, each consisting of one Class A ordinary share and one-fifth
VGII.U
$9.93M 0.05%
+1,000,000
New +$9.95M
FMIVU
133
DELISTED
Forum Merger IV Corporation Unit
FMIVU
$9.9M 0.05%
+1,000,000
New +$9.94M
TWNT.U
134
DELISTED
Tailwind Two Acquisition Corp. Units, each consisting of one Class A ordinary share and one-third of
TWNT.U
$9.88M 0.05%
+1,000,000
New +$10M
CAS
135
DELISTED
Cascade Acquisition Corp.
CAS
$9.7M 0.05%
+990,000
New +$10M
TECX
136
Tectonic Therapeutic
TECX
$736M
$9.39M 0.05%
61,667
-4,583
-7% -$745K
ALBO
137
DELISTED
Albireo Pharma Inc
ALBO
$8.81M 0.04%
250,000
– –
SVRA icon
138
Savara
SVRA
$1.15B
$8.58M 0.04%
4,125,877
-326,209
-7% -$558K
ARYD
139
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$8.32M 0.04%
+800,000
New +$8.64M
BOLT icon
140
Bolt Biotherapeutics
BOLT
$7.07M
$8.23M 0.04%
+12,500
New +$8.13M
JWSM.U
141
DELISTED
Jaws Mustang Acquisition Corp. Units, each consisting of one Class A ordinary share, and one-fourth of one redeemable warrant
JWSM.U
$8.12M 0.04%
+800,000
New +$8.36M
LVRAU
142
DELISTED
Levere Holdings Corp. Unit
LVRAU
$7.97M 0.04%
+800,000
New +$8.01M
SURF
143
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$7.8M 0.04%
1,000,000
– –
KNTE
144
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$7.79M 0.04%
250,000
– –
RACB
145
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
$7.69M 0.04%
+750,000
New +$7.68M
GMIIU
146
DELISTED
Gores Metropoulos II, Inc. Unit
GMIIU
$7.59M 0.04%
+750,000
New +$8M
WPCA.U
147
DELISTED
Warburg Pincus Capital Corporation I-A Units, each consisting of one Class A ordinary share, and one-fifth of one redeemable warrant
WPCA.U
$7.56M 0.04%
+750,000
New +$7.58M
RTPYU
148
DELISTED
Reinvent Technology Partners Y Unit
RTPYU
$7.53M 0.04%
+750,000
New +$7.55M
ACTDU
149
DELISTED
ArcLight Clean Transition Corp. II Unit
ACTDU
$7.5M 0.04%
+750,000
New +$7.5M
APGB.U
150
DELISTED
Apollo Strategic Growth Capital II Units, each consisting of one Class A ordinary share, and one-fifth of one warrant
APGB.U
$7.49M 0.04%
+750,000
New +$7.72M
4 5
6
7 8

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q1 2021 Portfolio in Review

As of Q1 2021, Thomas Steyer held 257 positions worth $20.1B, up 21% from $16.6B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Thomas Steyer deployed $2.5B of net new capital in Q1 2021, opening 120 new positions and adding to 40 existing holdings. Its largest new stake was Mastercard: 985,920 shares worth $351M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 39% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was New York Times, an estimated $209M trimmed.

  • Thomas Steyer's largest Q1 2021 buy was Mastercard: 985,920 shares worth $351M.
  • Thomas Steyer added most to Alexion Pharmaceuticals in Q1 2021, an estimated $546M increase.
  • Thomas Steyer's biggest Q1 2021 reduction was New York Times, cutting an estimated $209M.
  • Thomas Steyer fully exited Tiffany & Co. in Q1 2021, selling an estimated $301M.
  • Thomas Steyer's ten largest holdings make up 33% of its $20.1B portfolio in Q1 2021.
  • Thomas Steyer opened 120 new positions and closed 20 in Q1 2021.
  • Thomas Steyer's portfolio value rose 21% quarter-over-quarter to $20.1B.

Based on Farallon Capital Management's 13F filing for Q1 2021, filed 17 May 2021.